Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232829 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-08-22 | 2024-11-08 | 235695 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Actual shortage | 2025-08-07 | 2025-08-07 | 257170 |
| APO-LINEZOLID | 600MG | TABLET TABLET | Resolved | 2023-10-27 | 2023-11-10 | 208379 |
| APO-LINEZOLID | 600MG | TABLET TABLET | Resolved | 2022-05-13 | 2022-09-30 | 160607 |
| APO-LINEZOLID | 600MG | TABLET | Resolved | 2018-03-05 | 2019-11-04 | 41855 |
| APO-LISINOPRIL | 5MG | TABLET | Actual shortage | 2023-07-13 | 2025-01-30 | 198528 |
| APO-LISINOPRIL | 20MG | TABLET | Actual shortage | 2023-07-13 | 2024-04-05 | 198536 |
| APO-LISINOPRIL | 10MG | TABLET | Actual shortage | 2023-12-15 | 2024-04-05 | 213581 |
| APO-LISINOPRIL | 10MG | TABLET | Resolved | 2022-02-04 | 2022-03-24 | 154178 |
| APO-LISINOPRIL | 10MG | TABLET | Resolved | 2017-05-24 | 2017-06-23 | 11077 |
| APO-LISINOPRIL | 10MG | TABLET | Resolved | 2017-07-25 | 2018-02-09 | 17150 |
| APO-LISINOPRIL | 10MG | TABLET | Resolved | 2017-05-04 | 2017-06-23 | 8868 |
| APO-LISINOPRIL | 10MG | TABLET | Resolved | 2020-08-12 | 2020-10-05 | 122068 |
| APO-LISINOPRIL | 10MG | TABLET | Resolved | 2021-02-10 | 2021-03-15 | 133676 |
| APO-LISINOPRIL | 20MG | TABLET | Resolved | 2020-07-29 | 2020-10-05 | 121328 |
| APO-LISINOPRIL | 20MG | TABLET | Resolved | 2020-11-19 | 2021-03-15 | 128606 |
| APO-LISINOPRIL | 20MG | TABLET | Resolved | 2017-10-17 | 2018-01-26 | 26166 |
| APO-LISINOPRIL | 5MG | TABLET | Resolved | 2017-09-06 | 2017-12-31 | 21085 |
| APO-LISINOPRIL | 5MG | TABLET | Resolved | 2020-08-19 | 2020-10-05 | 122483 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |